Parkinson's Disease clinical trials
Showing 301–314 of 314 active trials. Describe your situation to see which ones look like a fit.
- Study in Parkinson Disease of Exercise
- Dysarthria Management for Minor Groups
- A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
- Rock Steady Boxing: A Community Based In Person Class
- Slow Wave Sleep As a Biomarker of Rehabilitation-induced Cognitive Improvement in PD
- Parkinson's Disease in Asian Americans
- Drug Discovery for Parkinson's With Mutations in the GBA Gene
- Neuroplasticity in Parkinson's Disease
- Pacific Northwest Udall Center (PANUC) Clinical Core
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
- Gait Analysis in Neurological Disease
- Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
- Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
- Occupational Therapy Led Social Prescription for People With Parkinson Disease
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.